Voriconazole-Induced Hepatotoxicity in a Patient with Pulmonary Aspergillosis: A Case Report
Li Gu,1 Tao Ai,2 Ling Pang,1 Dong Xu,1 Han Wang3 1Department and Institute of Infectious Disease, Tongji Hospital, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonostic Infectious Disease, Huazhong University of Science and Technology, Wuhan, Hubei Province,...
Main Authors: | Gu L, Ai T, Pang L, Xu D, Wang H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-08-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/voriconazole-induced-hepatotoxicity-in-a-patient-with-pulmonary-asperg-peer-reviewed-fulltext-article-IDR |
Similar Items
-
Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis
by: Sacha Sarfati, et al.
Published: (2022-07-01) -
Hepatotoxicity Due to Azole Antimycotic Agents in a HLA B*35:02-Positive Patient
by: Tim Bühler, et al.
Published: (2019-06-01) -
Treatment of Aspergillosis
by: Jeffrey D. Jenks, et al.
Published: (2018-08-01) -
Enhancing voriconazole therapy in liver dysfunction: exploring administration schemes and predictive factors for trough concentration and efficacy
by: Yichang Zhao, et al.
Published: (2024-01-01) -
Pharmacoeconomic evaluation of isavuconazole, posaconazole, and voriconazole for the treatment of invasive mold diseases in hematological patients: initial therapy prior to pathogen differential diagnosis in China
by: Guangxin Han, et al.
Published: (2023-12-01)